ADVAIR DISKUS (FLUTICASONE PROPIONATE AND SALMETEROL)
ADVAIR DISKUS (FLUTICASONE PROPIONATE AND SALMETEROL) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: ADVAIR DISKUS; Generic name: FLUTICASONE PROPIONATE AND SALMETEROL; Manufacturer: A-S Medication Solutions.
| Brand name | ADVAIR DISKUS |
|---|---|
| Generic name | FLUTICASONE PROPIONATE AND SALMETEROL |
| Manufacturer | A-S Medication Solutions |
| Used for | 1 INDICATIONS AND USAGE ADVAIR DISKUS is a combination product containing a corticosteroid and a long-acting beta 2 -adrenergic agonist (LABA) indicated for: • Twice-daily treatment of asthma in patients aged 4 years and older. ( 1.1 ) • Maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD). ( 1.2 ) Important limitation of use: Not indicated for relief of acute bronchospasm. ( 1.1 , 1.2 ) 1.1 Treatment of Asthma ADVAIR DISKUS is indicated for the twice-daily treatment of asthma in patients aged 4 years and older. ADVAIR DISKUS should be used for patients not adequately controlled on a long-term asthma control med |
| Dosage | 2 DOSAGE AND ADMINISTRATION ADVAIR DISKUS should be administered as 1 inhalation twice daily by the orally inhaled route only. After inhalation, the patient should rinse his/her mouth with water without swallowing to help reduce the risk of oropharyngeal candidiasis. More frequent administration or a greater number of inhalations (more than 1 inhalation twice daily) of the prescribed strength of ADVAIR DISKUS is not recommended as some patients are more likely to experience adverse effects with |
| Active ingredient(s) | FLUTICASONE PROPIONATE |
| Route | RESPIRATORY (INHALATION) |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17dd0a86-8161-4aa9-9b90-a23d81b38164 |